Efficacy and safety of tildrakizumab for the treatment of moderate-to-severe plaque psoriasis of the scalp: A multicenter, randomized, double-blind, placebo-controlled, Phase 3b study

Scalp psoriasis is common and difficult to treat.

Source: Journal of the American Academy of Dermatology - March 28, 2024 Category: Dermatology Authors: Kurt Gebauer, Lynda Spelman, Paul S. Yamauchi, Jerry Bagel, Tushar Nishandar, Michael Crane, Iris Kopeloff, Mudgal Kothekar, Siu-Long Yao, Howard L. Sofen Source Type: research